文献速递免疫规划传染病防控与疫情报告

GMZ2疟疾疫苗在终身暴露成人中诱导免疫调节通路并影响感染风险

Effect of immune regulatory pathways after immunization with GMZ2 malaria vaccine candidate in healthy lifelong malaria-exposed adults.
PubMed 文献 · Vaccine · 2020-05-05

免疫后sHLA-G和Treg反应增强,sHLA-G升高与抗GMZ2 IgG下降及CHMI后疟原虫感染风险增加相关。

要点

  • GMZ2接种后sHLA-G浓度普遍升高,CAF01佐剂组Treg频率增加。
  • D84 sHLA-G水平与抗GMZ2 IgG浓度呈负相关。
  • sHLA-G D84:D0比值高于中位数者CHMI后感染风险增加。

核心结论

  • 免疫接种可诱导调节性免疫反应,较强的sHLA-G和Treg反应可能抑制疫苗诱导的免疫应答。
  • sHLA-G反应幅度增加可提高CHMI后恶性疟原虫感染风险。

研究设计与样本

  • 仅使用35名参与者接种前(D0)和第三剂后28天(D84)的血浆和PBMC检测sHLA-G、抗GMZ2 IgG、Treg、Breg和浆母细胞。
  • 采用直接静脉接种恶性疟原虫子孢子的控制性人类疟疾感染(CHMI)评估疫苗效力。

主要发现

  • 所有GMZ2接种组和对照组从D0到D84 sHLA-G浓度均升高。
  • 仅30 µg或100 µg GMZ2-CAF01组Treg频率增加。
  • D84 sHLA-G水平与抗GMZ2 IgG浓度下降相关。
  • D0或D84的Treg频率及D84的Breg频率与较低浆母细胞频率相关。
  • sHLA-G D84:D0比值高于中位数与子孢子注射后恶性疟原虫感染风险增加相关。

临床怎么用

  • 在疟疾暴露人群中评估疫苗免疫原性时需考虑sHLA-G和Treg等调节性免疫反应对疫苗效果的潜在抑制作用。
  • sHLA-G反应幅度可作为候选疟疾疫苗在半免疫个体中感染风险的潜在监测指标。

局限性

  • 仅35名参与者的样本用于免疫学检测,样本量有限。
  • 原文未报告疫苗效力的具体数值及统计显著性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite appreciable immunogenicity in malaria-naive populations, many candidate malaria vaccines are considerably less immunogenic in malaria-exposed populations. This could reflect induction of immune regulatory mechanisms involving Human Leukocyte Antigen G (HLA-G), regulatory T (Treg), and regulatory B (Breg) cells. Here, we addressed the question whether there is correlation between these immune regulatory pathways and both plasmablast frequencies and vaccine-specific IgG concentrations. METHODS: Fifty Gabonese adults with lifelong exposure to Plasmodium spp were randomized to receive three doses of either 30 µg or 100 µg GMZ2-CAF01, or 100 µg GMZ2-alum, or control vaccine (rabies vaccine) at 4-week intervals. Only plasma and peripheral blood mononuclear cells isolated from blood samples collected before (D0) and 28 days after the third vaccination (D84) of 35 participants were used to measure sHLA-G levels and anti-GMZ2 IgG concentrations, and to quantify Treg, Breg and plasmablast cells. Vaccine efficacy was assessed using controlled human malaria infection (CHMI) by direct venous inoculation of Plasmodium falciparum sporozoites (PfSPZ Challenge). RESULTS: The sHLA-G concentration increased from D0 to D84 in all GMZ2 vaccinated participants and in the control group, whereas Treg frequencies increased only in those receiving 30 µg or 100 µg GMZ2-CAF01. The sHLA-G level on D84 was associated with a decrease of the anti-GMZ2 IgG concentration, whereas Treg frequencies on D0 or on D84, and Breg frequency on D84 were associated with lower plasmablast frequencies. Importantly, having a D84:D0 ratio of sHLA-G above the median was associated with an increased risk of P. falciparum infection after sporozoites injection. CONCLUSION: Regulatory immune responses are induced following immunization. Stronger sHLA-G and Treg immune responses may suppress vaccine induced immune responses, and the magnitude of the sHLA-G response increased the risk of Plasmodium falciparum infection after CHMI. These findings could have implications for the design and testing of malaria vaccine candidates in semi-immune individuals.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Nouatin O, Ateba Ngoa U, Ibáñez J, et al. Effect of immune regulatory pathways after immunization with GMZ2 malaria vaccine candidate in healthy lifelong malaria-exposed adults. Vaccine. 2020. PMID: 32386747. doi:10.1016/j.vaccine.2020.04.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。